Lipoxygenase products modulate histamine release in human basophils
Lipoxygenase products modulate histamine release in human basophils
复制标题
脂氧合酶产品调节人嗜碱性粒细胞中的组胺释放
DOI:
10.1038/292455a0
复制
发表时间:
1981
期刊:
影响因子:
64.8
通讯作者:
L. Lichtenstein
中科院分区:
文献类型:
--
作者:
S. Peters;M. Siegel;A. Kagey;L. Lichtenstein
Arachidonic acid released from cellular phospholipids is metabolized by two major enzyme systems1. The cyclo-oxygenase pathways are responsible for the production of prostaglandins, thromboxanes and prostacyclin while the lipoxygenase pathways form a series of monoperoxy- and monohydroxyeicosatetraenoic acids. The 5-lipoxygenase pathway eventually leads to the production of both leukotriene B, one of the most potent chemotactic molecules known, and SRS-A (slow-reacting substance of anaphylaxis—leukotrienes C and D). Our earlier studies of the lipoxygenase enzyme(s) suggested that a product (s) of lipoxygenase (s) is both necessary for histamine release from human basophils and blunts endogenous control mechanisms2–4. To test this hypothesis, we have studied the effect of exogenously added products of lipoxygenase pathways on antigen-induced histamine release from human basophilic leukocytes in vitro. The present report demonstrates that 5-hydroperoxyeicosatetraenoic acid (5-HPETE), at sub-micromolar concentrations, causes both a dose-dependent enhancement of histamine release and a reversal of the inhibition of histamine release caused by hormones and other agonists which act via adenylate cyclase. The reduced product of 5-HPETE, 5-hydroxyeicosatetraenoic acid (5-HETE) has both activities, but is approximately 3 to 10 times less potent.